TW202017585A - Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells - Google Patents
Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells Download PDFInfo
- Publication number
- TW202017585A TW202017585A TW107140453A TW107140453A TW202017585A TW 202017585 A TW202017585 A TW 202017585A TW 107140453 A TW107140453 A TW 107140453A TW 107140453 A TW107140453 A TW 107140453A TW 202017585 A TW202017585 A TW 202017585A
- Authority
- TW
- Taiwan
- Prior art keywords
- gene
- skin
- item
- fermented
- patent application
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 34
- 102000008186 Collagen Human genes 0.000 title claims abstract description 28
- 108010035532 Collagen Proteins 0.000 title claims abstract description 28
- 229920001436 collagen Polymers 0.000 title claims abstract description 28
- 210000004927 skin cell Anatomy 0.000 title claims abstract description 28
- 230000014509 gene expression Effects 0.000 title claims abstract description 27
- 102000016942 Elastin Human genes 0.000 title claims abstract description 26
- 108010014258 Elastin Proteins 0.000 title claims abstract description 26
- 229920002549 elastin Polymers 0.000 title claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 20
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 20
- 108090000320 Hyaluronan Synthases Proteins 0.000 title claims abstract description 19
- 102000003918 Hyaluronan Synthases Human genes 0.000 title claims abstract description 18
- 108010076876 Keratins Proteins 0.000 title claims abstract description 18
- 230000001737 promoting effect Effects 0.000 title claims abstract description 16
- 102000011782 Keratins Human genes 0.000 title claims abstract description 12
- 102100028314 Filaggrin Human genes 0.000 title claims abstract description 7
- 101710088660 Filaggrin Proteins 0.000 title claims abstract description 4
- 230000035755 proliferation Effects 0.000 title abstract description 23
- 239000003963 antioxidant agent Substances 0.000 title abstract description 21
- 241001598107 Imperata Species 0.000 title abstract description 6
- 238000000855 fermentation Methods 0.000 claims abstract description 26
- 230000004151 fermentation Effects 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 19
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims description 61
- 244000221633 Brassica rapa subsp chinensis Species 0.000 claims description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 22
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 18
- 150000004676 glycans Chemical class 0.000 claims description 17
- 229920001282 polysaccharide Polymers 0.000 claims description 17
- 239000005017 polysaccharide Substances 0.000 claims description 17
- 241000723353 Chrysanthemum Species 0.000 claims description 15
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 15
- 241000186660 Lactobacillus Species 0.000 claims description 14
- 229940039696 lactobacillus Drugs 0.000 claims description 12
- 230000000813 microbial effect Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 claims description 6
- 108010066321 Keratin-14 Proteins 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 4
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 230000004663 cell proliferation Effects 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 101000614436 Homo sapiens Keratin, type I cytoskeletal 14 Proteins 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 53
- 210000002510 keratinocyte Anatomy 0.000 abstract description 26
- 230000003020 moisturizing effect Effects 0.000 abstract description 14
- 210000000434 stratum corneum Anatomy 0.000 abstract description 14
- 230000008591 skin barrier function Effects 0.000 abstract description 8
- 230000009759 skin aging Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 48
- 239000000047 product Substances 0.000 description 22
- 235000006708 antioxidants Nutrition 0.000 description 19
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 101150063233 FLG gene Proteins 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 101150027313 Has2 gene Proteins 0.000 description 12
- 101150040052 KRT14 gene Proteins 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241001079007 Phellodendron chinense Species 0.000 description 11
- 101150089672 HAS3 gene Proteins 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000001626 skin fibroblast Anatomy 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 239000012091 fetal bovine serum Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 239000007758 minimum essential medium Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 101710128038 Hyaluronan synthase Proteins 0.000 description 6
- 238000000692 Student's t-test Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000972673 Phellodendron amurense Species 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108010040897 Microfilament Proteins Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 229940126601 medicinal product Drugs 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 229940127557 pharmaceutical product Drugs 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 101150106024 Aqp3 gene Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 101150058971 KRT10 gene Proteins 0.000 description 3
- 101150056422 Krt1 gene Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 101150039702 TGM1 gene Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940054269 sodium pyruvate Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 2
- 101150071538 AQP gene Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 241000972672 Phellodendron Species 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 240000007332 Podocarpus macrophyllus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 206010050637 Skin tightness Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- -1 patch Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明係關於一白茅根發酵物之用途,尤其是一種白茅根發酵物用於提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力的用途。 The present invention relates to the use of a fermented pakchoi root, especially a fermented pakchoi root for enhancing the expression of skin cell keratin gene, polykeratin filament gene and hyaluronic acid synthase gene, promoting the proliferation of collagen and elastin, And the use of enhancing antioxidant capacity.
表皮層為皮膚的最外層,由外往內依序為角質層、顆粒層、有棘層及基底層,表皮層主要由基底層中未分化之圓柱型角質細胞持續向上進行分化形成,此過程稱為角質化。角質細胞內含水量高,隨著細胞向上代謝分化,角質細胞形狀會逐漸變成扁平狀,且細胞核及胞器開始退化萎縮,並在角質層形成不具細胞核與胞器之死細胞。表皮層的主要功能為使皮膚保水,並形成皮膚屏障以抵禦各種外來傷害,其中表皮層最外層由一弱酸性的皮脂膜以及如磚牆結構的角質層所構成,此屏障能鎖住皮膚的水分和油脂、抵抗皮膚表面病菌入侵,及對抗外界異物及紫外光等傷害,對人體有非常重要的保護作用。 The epidermal layer is the outermost layer of the skin, which is the stratum corneum, the granular layer, the spinous layer and the basal layer in sequence from the outer to the inner. The epidermal layer is mainly formed by the continuous differentiation of the undifferentiated cylindrical keratinocytes in the basal layer. This process Called keratinization. Keratinocytes have a high water content. As the cells metabolize and differentiate, the shape of the keratinocytes will gradually become flat, and the nuclei and organelles will begin to degenerate and shrink, and dead cells without nucleus and organelles will form in the stratum corneum. The main function of the epidermal layer is to keep the skin water-retaining and form a skin barrier to resist various external damages. The outermost layer of the epidermal layer is composed of a weakly acidic sebum film and the stratum corneum like a brick wall structure. This barrier can lock the skin. Moisture and oil, resist the invasion of bacteria on the skin surface, and resist the damage of foreign bodies and ultraviolet light, etc., have a very important protective effect on the human body.
表皮層中的角質層,其角質細胞雖然為死細胞,但其主要成分為角蛋白(keratin),角蛋白能吸收水分使皮膚保持濕潤,角質細胞也會分泌如玻尿酸等物質作為細胞間質,以維持表皮層皮膚屏障之結構完整,以防止皮膚水 分散失及形成完整防護。當皮膚接觸過冷或過熱之環境以及照射紫外光等刺激,會導致角質細胞無法維持正常的代謝循環,且皮膚保水能力也會下降,並導致皮膚表皮層屏障受損,讓皮膚變得粗糙、乾燥脫屑、脆弱易受刺激、敏感泛紅,因此角質層的健康與保水能力對於抵禦外來傷害著實非常重要。 In the stratum corneum of the epidermal layer, although the keratinocytes are dead cells, the main component is keratin. Keratin can absorb water to keep the skin moist. Keratinocytes also secrete substances such as hyaluronic acid as the intercellular substance. To maintain the structural integrity of the epidermal skin barrier to prevent skin water Disperse and form complete protection. When the skin is exposed to excessively cold or overheated environments and irradiated with ultraviolet light and other stimuli, the keratinocytes cannot maintain the normal metabolic cycle, and the skin's ability to retain water is also reduced, resulting in damage to the skin's epidermal barrier, making the skin rough, Dry and desquamated, fragile and susceptible to irritation, sensitive redness, so the health of the stratum corneum and the ability to retain water are very important to resist external damage.
綜合上面所述,因應講求天然健康的現代趨勢,為改善因角質細胞受損及保水能力下降,導致皮膚變得脆弱、易敏的問題,開發一種能有效使角質細胞分泌更多保濕因子,並維持角質細胞排列、維持角質層結構完整,以提升皮膚屏障功能的綜合皮膚保健組合物,著實有其必要性。 Based on the above, in response to the modern trend of natural health, in order to improve the problem that the skin becomes fragile and sensitive due to the damage of keratinocytes and the decline in water retention capacity, develop a kind of effective keratinocytes to secrete more moisturizing factors, and A comprehensive skin health care composition that maintains the arrangement of keratinocytes and maintains the structural integrity of the stratum corneum to enhance the skin barrier function is indeed necessary.
緣此,本發明之一目的在提供一種白茅根發酵物用於製備提升角蛋白(Keratin,KRT)基因、聚角蛋白微絲(Filaggrin,FLG)基因、及/或玻尿酸合成酶(Hyaluronan synthase,HAS)基因表現量之組合物的用途。 Therefore, one object of the present invention is to provide a fermented Pakchoi root for preparing keratin (Keratin, KRT ) gene, polykeratin microfilament (Filaggrin, FLG ) gene, and/or hyaluronan synthase (Hyaluronan synthase, HAS ) Use of a gene expression amount composition.
本發明之又一目的在提供一種白茅根發酵物用於製備促進皮膚細胞增生膠原蛋白及/或彈力蛋白之組合物的用途。 Another object of the present invention is to provide a use of fermented Pakchoi root to prepare a composition for promoting collagen and/or elastin in skin cell proliferation.
本發明之又一目的在提供一種白茅根發酵物用於製備提升皮膚細胞抗氧化活性之組合物的用途。 Another object of the present invention is to provide a use of the fermented Pakchoi root for preparing a composition for enhancing the antioxidant activity of skin cells.
本發明之另一目的在提供一種白茅根發酵物之製造方法,係包含:將一白茅根水萃取物經由一酵母菌、及一乳酸桿菌依序進行發酵而獲得;其中該白茅根發酵物係由一白茅根水萃取物與一微生物群之二階段發酵而得,其中該微生物群係由一酵母菌(Saccharomyces cerevisiae)、及一乳酸桿菌(Lactobacillus plantarum)所組成。 Another object of the present invention is to provide a method for producing fermented pakchoi root, which comprises: obtaining a water extract of pakchoi root through a yeast and a lactobacillus in order to ferment it in sequence; It is obtained by two-stage fermentation of a water extract of Rhizoma Imperatae and a microbial group, wherein the microbial group is composed of a yeast ( Saccharomyces cerevisiae ) and a Lactobacillus plantarum .
在本發明之一實施例中,其中該白茅根水萃取物係一白茅根以1:18-30之固液比例與水混合,並在50-100℃下滅菌萃取0.5-3小時所得;且該酵母菌係為BCRC20271之菌株、該乳酸桿菌係為BCRC910805之菌株;該酵母菌 之添加量為0.01-0.5%(v/v)、該乳酸桿菌之添加量0.01-0.25%(v/v);且該酵母菌、及該乳酸桿菌之培養時間分別皆係1-3天;且該發酵係提高白茅根之總多糖含量,其中該白茅根發酵物之總多糖至少為20%。 In an embodiment of the present invention, wherein the water extract of Phellodendron arundinacea root is obtained by mixing Phellodendron chinense with water at a solid-liquid ratio of 1:18-30 and sterilized extraction at 50-100°C for 0.5-3 hours; and The yeast strain is a strain of BCRC20271, and the lactobacillus strain is a strain of BCRC910805; the yeast The added amount is 0.01-0.5% (v/v), the added amount of the Lactobacillus is 0.01-0.25% (v/v); and the cultivation time of the yeast and the Lactobacillus are respectively 1-3 days; Moreover, the fermentation system increases the total polysaccharide content of Pakchoi root, wherein the total polysaccharide of Pakchoi root ferment is at least 20%.
在本發明之又一實施例中,該KRT基因係角蛋白14(Keratin14,KRT14)基因;且該HAS基因包含玻尿酸合成酶2(Hyaluronan synthase 2,HAS2)基因及玻尿酸合成酶3(Hyaluronan synthase 3,HAS3)基因。 In yet another embodiment of the present invention, the KRT gene is a keratin 14 (Keratin14, KRT14 ) gene; and the HAS gene includes a Hyaluronan synthase 2 (Hyaluronan synthase 2, HAS2 ) gene and a Hyaluronan synthase 3 (Hyaluronan synthase 3 , HAS3 ) gene.
本發明之白茅根發酵物在經過本發明微生物發酵步驟後,能有效提升其中效性成分總多糖的含量,以提升皮膚保濕的功效,並提升皮膚角質層結構之完整;亦能藉由有效提高KRT14基因、FLG基因、HAS2基因及HAS3基因的表現量,而有效使皮膚角質分泌更多保濕因子,並使皮膚保濕能力上升、維持角質細胞排列、維持角質層結構完整,以提升皮膚屏障功能;亦能有效促進皮膚細胞的膠原蛋白增生,並能使皮膚恢復光滑緊致,以提升皮膚飽水度使皮膚豐盈細滑;亦能有效促進皮膚細胞的彈力蛋白增生,以維持皮膚緊實有彈性,並減少皮膚的皺紋產生使皮膚豐盈細滑;以及能有效清除皮膚細胞中的自由基,能提升皮膚細胞抗氧化能力,以防止皮膚老化的發生。因此,本發明之白茅根發酵物可用於製備提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力之組合物的用途,該組合物該組合物是一醫藥品、一食品或一保養品,可藉由口服、皮膚塗抹等方式給予一個體。 After passing through the microbial fermentation step of the present invention, the fermented chrysanthemum root of the present invention can effectively increase the content of the total polysaccharide in the effective component to improve the skin moisturizing effect and enhance the integrity of the skin cuticle structure; it can also be effectively improved The expression levels of KRT14 gene, FLG gene, HAS2 gene and HAS3 gene can effectively make the skin keratin secret more moisturizing factors, and increase the skin's moisturizing ability, maintain the arrangement of keratinocytes and maintain the integrity of the stratum corneum structure to enhance the skin barrier function; It can also effectively promote the proliferation of collagen in skin cells, and can restore skin smoothness and firmness, so as to increase skin saturation and make the skin plump and smooth; it can also effectively promote the proliferation of elastin in skin cells to maintain skin firmness and elasticity And reduce the generation of wrinkles on the skin to make the skin plump and smooth; and can effectively remove free radicals in skin cells, can enhance the antioxidant capacity of skin cells to prevent the occurrence of skin aging. Therefore, the fermented roots of the present invention can be used to prepare a composition for enhancing the expression of skin keratin gene, polykeratin filament gene and hyaluronic acid synthase gene, promoting the proliferation of collagen and elastin, and enhancing the antioxidant capacity Use, the composition The composition is a medicinal product, a food or a care product, and can be administered to a body by oral administration, skin application, or the like.
以下將進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明,並非用以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The embodiments of the present invention will be further described below. The examples listed below are used to clarify the present invention, and are not intended to limit the scope of the present invention. Anyone who is familiar with this art, without departing from the spirit and scope of the present invention, Some changes and retouching can be done, so the scope of protection of the present invention shall be deemed as defined by the scope of the attached patent application.
圖1係為本發明之一實施例白茅根發酵物與白茅根水萃取物中總多糖含量比較之長條圖。 FIG. 1 is a bar graph showing the comparison of the total polysaccharide content in the water extract of Phellodendron chinense L. fermented and P. chinensis root according to an embodiment of the present invention.
圖2係為本發明之一實施例白茅根發酵物提升KRT14基因、FLG基因、HAS2基因及HAS3基因表現量之效果的長條圖;** p<0.01。 FIG. 2 is a bar graph of the effect of the fermented Phellodendron amurense L. on raising the expression level of the KRT14 gene, FLG gene, HAS2 gene and HAS3 gene; ** p<0.01.
圖3係為本發明之一實施例白茅根發酵物促進膠原蛋白增生之效果的長條圖;** p<0.01;### p<0.001。 FIG. 3 is a bar graph of the effect of fermented Phellodendron amurense promoting collagen proliferation according to an embodiment of the present invention; ** p<0.01; ### p<0.001.
圖4係為本發明之一實施例白茅根發酵物促進彈力蛋白增生之效果的長條圖;** P<0.01;## p<0.01。 FIG. 4 is a bar graph of the effect of fermented Phellodendron amurense promoting elastin proliferation according to an embodiment of the present invention; ** P<0.01; ## p<0.01.
圖5係為本發明之一實施例白茅根發酵物提升細胞抗氧化能力之效果的長條圖;*** p<0.001;### p<0.001。 FIG. 5 is a bar graph of the effect of the fermented Phellodendron amurense L. cellulite to enhance the antioxidant capacity of cells according to an embodiment of the invention; *** p<0.001; ### p<0.001.
本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used in this article are approximate values, and all experimental data are expressed within a range of 20%, preferably within a range of 10%, and most preferably within a range of 5%.
使用Excel軟體進行統計分析。數據以平均值±標準差(SD)表示,個此之間的差異以學生t檢驗(student's t-test)分析。 Use Excel software for statistical analysis. Data mean ± standard deviation (SD) represented by the difference between the two herein by Student t test (student's t -test) analysis.
白茅根(Imperata cylindrica)為禾本科(Gramineae)茅根屬(Imperata)多年生草本植物,又稱茅草、白茅草、茅根,植株高20~80公分,根莖呈白色,橫走於地下,節部生有鱗片,尖端有甜味,單葉互生,集中於基部,老時基部常有破碎呈纖維狀的葉鞘,葉片扁平,呈條狀或條狀披針形,夏季開花,花為銀白色,分枝密集。目前已知白茅根具有清熱潤肺、生津解毒、健肝養脾功效,降火生津、涼血、利尿等功效。 Imperata cylindrica is a perennial herbaceous plant of the Gramineae genus Imperata . It is also known as thatch, chrysanthemum, and chrysanthemum. The plant is 20-80 cm tall. The rhizome is white and runs horizontally under the ground. Scales, sweet tip, alternate leaves, concentrated on the base, when old, the base often has broken and fibrous leaf sheaths, flat leaves, strips or strips lanceolate, bloom in summer, flowers are silvery white, densely branched . At present, it is known that Baimaogen has the effects of clearing away heat and nourishing the lung, regenerating the body and detoxifying, strengthening the liver and nourishing the spleen, lowering the fire and regenerating the body, cooling blood and diuresis.
如本文中所使用的,用語「白茅根發酵物」意為白茅根水萃取物以酵母菌及乳酸桿菌經一二段式發酵而得,其中白茅根水萃取物是白茅根與溶劑以1:18-30(w/w)比例經一時間與溫度萃取而得。 As used in this article, the term "fermenta root ferment" means that the water extract of Pakchoi root is fermented by yeast and Lactobacillus in one or two stages, wherein the water extract of Pakchoi root is Pakchoi root and the solvent is 1: The ratio of 18-30 (w/w) is obtained by extraction with time and temperature.
依據本發明,醫藥品可利用熟習此技藝者所詳知的技術而被製造成一適合於非經腸道地(parenterally)或局部地(topically)投藥的劑型,這包括,但不限於:注射品(injection)[例如,無菌的水性溶液(sterile aqueous solution)或分散液(dispersion)]、無菌的粉末(sterile powder)、外部製劑(external preparation)以及類似之物。 According to the present invention, pharmaceutical products can be manufactured into a dosage form suitable for parenterally or topically administration using techniques well known to those skilled in the art, including, but not limited to: injections (injection) [for example, sterile aqueous solution or dispersion], sterile powder, external preparation, and the like.
依據本發明,醫藥品可進一步包含有一被廣泛地使用於藥物製造技術之醫藥上可接受的載劑(pharmaceutically acceptable carrier)。例如,該醫藥上可接受的載劑可包含一或多種選自於下列的試劑:溶劑(solvent)、緩衝液(buffer)、乳化劑(emulsifier)、懸浮劑(suspending agent)、分解劑(decomposer)、崩解劑(disintegrating agent)、分散劑(dispersing agent)、黏結劑(binding agent)、賦形劑(excipient)、安定劑(stabilizing agent)、螯合劑(chelating agent)、稀釋劑(diluent)、膠凝劑(gelling agent)、防腐劑(preservative)、潤濕劑(wetting agent)、潤滑劑(lubricant)、吸收延遲劑(absorption delaying agent)、脂質體(liposome)以及類似之物。有關這些試劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the pharmaceutical product may further include a pharmaceutically acceptable carrier widely used in pharmaceutical manufacturing technology. For example, the pharmaceutically acceptable carrier may include one or more agents selected from the group consisting of solvents, buffers, emulsifiers, suspending agents, and decomposers ), disintegrating agent, dispersing agent, binding agent, excipient, stabilizing agent, chelating agent, diluent , Gelling agent, preservative, wetting agent, lubricant, absorption delaying agent, liposome, and the like. The selection and quantity of these reagents fall within the professional qualities and routine techniques of those who are familiar with this technology.
依據本發明,該醫藥上可接受的載劑包含有一選自於由下列所構成之群組中的溶劑:水、生理鹽水(normal saline)、磷酸鹽緩衝生理鹽水(phosphate buffered saline,PBS)、含有醇的水性溶液(aqueous solution containing alcohol)以及它們的組合。 According to the present invention, the pharmaceutically acceptable carrier contains a solvent selected from the group consisting of water, normal saline, phosphate buffered saline (PBS), Aqueous solution containing alcohol and their combination.
依據本發明,該醫藥品可以一選自於由下列所構成之群組中的非經腸道途徑(parenteral routes)來投藥:皮下注射(subcutaneous injection)、表皮內 注射(intraepidermal injection)、皮內注射(intradermal injection)以及病灶內注射(intralesional injection)。 According to the present invention, the medicinal product can be administered by parenteral routes selected from the group consisting of subcutaneous injection, intradermal Injection (intraepidermal injection), intradermal injection (intradermal injection) and intralesional injection (intralesional injection).
依據本發明,醫藥品可利用熟習此技藝者所詳知的技術而被製造成一適合於局部地施用於皮膚上的外部製劑(external preparation),這包括,但不限於:乳劑(emulsion)、凝膠(gel)、軟膏(ointment)、乳霜(cream)、貼片(patch)、擦劑(liniment)、粉末(powder)、氣溶膠(aerosol)、噴霧(spray)、乳液(lotion)、乳漿(serum)、糊劑(paste)、泡沫(foam)、滴劑(drop)、懸浮液(suspension)、油膏(salve)以及繃帶(bandage)。 According to the present invention, pharmaceutical products can be manufactured into an external preparation suitable for topical application to the skin using techniques well known to those skilled in the art, which include, but are not limited to: emulsion, gel Gel, ointment, cream, patch, liniment, powder, aerosol, spray, lotion, milk Serums, pastes, foams, drops, suspensions, salves and bandages.
依據本發明,該外部製劑是藉由將本發明的醫藥品與一為熟習此項技藝者所詳知的基底(base)相混合而被製備。 According to the present invention, the external preparation is prepared by mixing the pharmaceutical product of the present invention with a base well known to those skilled in the art.
依據本發明,該基底可包含有一或多種選自於下列的添加劑(additives):水、醇(alcohols)、甘醇(glycol)、碳氫化合物(hydrocarbons)[諸如石油膠(petroleum,jelly)以及白凡士林(white petrolatum,)]、蠟(wax)[諸如石蠟(paraffin)以及黃蠟(yellow wax)]、保存劑(preserving agents)、抗氧化劑(antioxidants)、界面活性劑(surfactants)、吸收增強劑(absorption enhancers)、安定劑(stabilizing agents)、膠凝劑(gelling agents)[諸如卡波普®974P(carbopol®974P)、微結晶纖維素(microcrystalline cellulose)以及羧基甲基纖維素(carboxymethylcellulose)]、活性劑(active agents)、保濕劑(humectants)、氣味吸收劑(odor absorbers)、香料(fragrances)、pH調整劑(pH adjusting agents)、螯合劑(chelating agents)、乳化劑(emulsifiers)、閉塞劑(occlusive agents)、軟化劑(emollients)、增稠劑(thickeners)、助溶劑(solubilizing agents)、滲透增強劑(penetration enhancers)、抗刺激劑(anti-irritants)、著色劑(colorants)以及推進劑(propellants)等。有關這些添加劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the substrate may include one or more additives selected from the group consisting of water, alcohols, glycols, hydrocarbons [such as petroleum, jelly, and White petrolatum (white petrolatum,)], wax [such as paraffin and yellow wax], preserving agents (antiserving agents), antioxidants (antioxidants), surfactants (surfactants), absorption enhancers (absorption enhancers), stabilizers, gelling agents [such as carbopol ® 974P (carbopol ® 974P), microcrystalline cellulose (microcrystalline cellulose) and carboxymethylcellulose (carboxymethylcellulose)] , Active agents, humectants, odor absorbers, fragrances, pH adjusting agents, chelating agents, emulsifiers, occlusions Occlusive agents, emollients, thickeners, solubilizing agents, penetration enhancers, anti-irritants, colorants and propellants Agent (propellants) and so on. The selection and quantity of these additives fall within the scope of professional qualities and routine skills of those who are familiar with this technology.
依據本發明,保養品可進一步包含有一被廣泛地使用於保養品製造技術之可接受的佐劑(acceptable adjuvant)。例如,該可接受的佐劑可包含有一或多種選自於下列的試劑:溶劑、膠凝劑、活性劑、防腐劑、抗氧化劑、遮蔽劑(screening agent)、螯合劑、界面活性劑、染色試劑(coloring agent)、增稠劑(thickening agent)、填料(filler)、香料以及氣味吸收劑。有關這些試劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the maintenance product may further include an acceptable adjuvant widely used in the maintenance product manufacturing technology. For example, the acceptable adjuvant may contain one or more agents selected from the group consisting of solvents, gelling agents, active agents, preservatives, antioxidants, screening agents, chelating agents, surfactants, dyes Coloring agent, thickening agent, filler, fragrance and odor absorber. The selection and quantity of these reagents fall within the professional qualities and routine techniques of those who are familiar with this technology.
依據本發明,保養品可利用熟習此技藝者所詳知的技術而被製造成一適合於護膚(skincare)或化妝(makeup)的形式,這包括,但不限於:水性溶液(aqueous solution)、水-醇溶液(aqueous-alcohol solution)或油性溶液(oily solution)、呈水包油型(oil-in-water type)、油包水型(water-in-oil type)或複合型之乳劑、凝膠、軟膏、乳霜、面膜(mask)、貼片、貼布(pack)、擦劑、粉末、氣溶膠、噴霧、乳液、乳漿、糊劑、泡沫、分散液、滴劑、慕斯(mousse)、防曬油(sunblock)、化妝水(tonic water)、粉底(foundation)、卸妝產品(makeup remover products)、肥皂(soap)以及其他身體清潔產品(body cleansing products)等。 According to the present invention, skin care products can be manufactured into a form suitable for skincare or makeup using techniques well known to those skilled in the art. This includes, but is not limited to: aqueous solution (aqueous solution), water -Aqueous-alcohol solution or oily solution, oil-in-water type, water-in-oil type or compound emulsion, gel Glue, ointment, cream, mask, patch, pack, wipe, powder, aerosol, spray, emulsion, emulsion, paste, foam, dispersion, drops, mousse ( mousse, sunblock, tonic water, foundation, foundation remover products, makeup remover products, soap, and other body cleansing products.
依據本發明,保養品亦可與一或多種選自於下列之已知活性的外用劑(external use agents)一起合併使用:美白劑(whitening agents)[諸如維生素A酸(tretinoin)、兒茶素(catechin)、麴酸、熊果苷以及維生素C]、保濕劑、抗發炎劑(anti-inflammatory agents)、殺菌劑(bactericides)、紫外線吸收劑(ultraviolet absorbers)、植物萃取物(plant extracts)[諸如蘆薈萃取物(aloe extract)]、皮膚營養劑(skin nutrients)、麻醉劑(anesthetics)、抗痘劑(anti-acne agents)、止癢劑(antipruritics)、止痛劑(analgesics)、抗皮膚炎劑(antidermatitis agents)、抗過角化劑(antihyperkeratolytic agents)、抗乾皮膚劑(anti-dry skin agents)、抗汗劑(antipsoriatic agents)、抗老化劑(antiaging agents)、抗皺劑(antiwrinkle agents)、抗皮脂溢出劑(antiseborrheic agents)、傷口治療劑(wound-healing agents)、皮質 類固醇(corticosteroids)以及激素(hormones)。有關這些外用劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the skin care product can also be used in combination with one or more external use agents of known activity selected from the following: whitening agents [such as tretinoin, catechins (catechin), kojic acid, arbutin and vitamin C], humectants, anti-inflammatory agents, bactericides, ultraviolet absorbers, plant extracts[plant extracts][ Such as aloe extract], skin nutrients, anesthetics, anti-acne agents, antipruritics, analgesics, anti-dermatitis agents (antidermatitis agents), antihyperkeratolytic agents, anti-dry skin agents, antipsoriatic agents, antiaging agents, antiwrinkle agents, Antiseborrheic agents, wound-healing agents, cortex Corticosteroids and hormones. The selection and quantity of these external agents fall within the professional qualities and routine technologies of those who are familiar with this technology.
依據本發明,食品產品可被當作食品添加物(food additive),藉由習知方法於原料製備時添加,或是於食品的製作過程中添加,而與任一種可食性材料配製成供人類與非人類動物攝食的食品產品。 According to the present invention, a food product can be used as a food additive, which is added during the preparation of raw materials by conventional methods, or added during the production of food, and formulated with any edible material for Food products consumed by humans and non-human animals.
依據本發明,食品產品的種類包括但不限於:飲料(beverages)、發酵食品(fermented foods)、烘培產品(bakery products)、健康食品(health foods)以及膳食補充品(dietary supplements)。 According to the present invention, the types of food products include, but are not limited to: beverages, fermented foods, bakery products, health foods, and dietary supplements.
本發明提供一種白茅根發酵物用於製備提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力之組合物的用途,本發明之白茅根發酵物是將白茅根水萃取物以酵母菌及乳酸桿菌進行二段式發酵所得之白茅根發酵物,其中白茅根水萃取物係以一溶劑萃取一白茅根所獲得,該溶劑為水、醇、或醇水混合物,本發明之白茅根發酵物可用於提升KRT14基因、FLG基因、HAS2基因及HAS3基因的表現量、促進皮膚細胞的膠原蛋白及彈力蛋白的增生、使皮膚保濕能力上升、維持角質細胞排列、維持角質層結構完整、及提升皮膚細胞抗氧化能力。 The invention provides a use of a fern of Phellodendron chinense to prepare a composition for enhancing the expression of skin keratin gene, polykeratin microfilament gene and hyaluronic acid synthase gene, promoting the proliferation of collagen and elastin, and enhancing the antioxidant capacity The fermented radix chrysanthemum of the present invention is a fermented radix chrysanthemum fermented by two-stage fermentation of the water extract of chrysanthemum root with yeast and Lactobacillus. The solvent is water, alcohol, or a mixture of alcohol and water. The fermented Pakchoi root of the present invention can be used to enhance the expression of KRT14 gene, FLG gene, HAS2 gene and HAS3 gene, promote the proliferation of collagen and elastin of skin cells, and make Increased skin moisturizing ability, maintain the arrangement of keratinocytes, maintain the integrity of the stratum corneum structure, and enhance the antioxidant capacity of skin cells.
同時,本發明用於製備提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力之組合物,亦可包含一有效量之白茅根發酵物及一醫藥上可接受之載體,該組合物係一醫藥品、一食品或一保養品。 At the same time, the present invention is used to prepare a composition for enhancing the expression of skin cell keratin gene, polykeratin microfilament gene and hyaluronic acid synthase gene, promoting the proliferation of collagen and elastin, and enhancing the antioxidant capacity, and may also contain an effective The amount of fermented Pakchoi root and a pharmaceutically acceptable carrier, the composition is a medicinal product, a food or a maintenance product.
以下將詳細說明本發明白茅根發酵物之詳細製備方法,與該白茅根發酵物於總多糖含量提升之測試、於提升KRT基因、FLG基因、HAS基因之測試、於促進皮膚細胞增生膠原蛋白之測試、促進皮膚細胞增生彈力蛋白之測試、以及於提升細胞抗氧化能力之測試,以證實該白茅根發酵物對於提升KRT14 基因、FLG基因、HAS2基因及HAS3基因的表現量、促進皮膚細胞的膠原蛋白及彈力蛋白的增生、使皮膚保濕能力上升、維持角質細胞排列、維持角質層結構完整、及提升皮膚細胞抗氧化能力之功效。 The detailed preparation method of the fermented Pakchoi root of the present invention will be described in detail below, together with the test of the fermented Pakchoi root fermented substance in the increase of total polysaccharide content, the test of the elevated KRT gene, FLG gene, HAS gene, and the promotion of skin cell hyperplasia collagen Tests, tests to promote the proliferation of elastin in skin cells, and tests to enhance the antioxidant capacity of cells to confirm that the fermented Pakchoi root promotes the expression of KRT14 gene, FLG gene, HAS2 gene and HAS3 gene, and promotes the collagen of skin cells Proliferation of protein and elastin, increase the skin's moisturizing ability, maintain the arrangement of keratinocytes, maintain the integrity of the stratum corneum structure, and enhance the antioxidant capacity of skin cells.
在本發明一實施例中,將白茅根徹底清洗,取洗淨後之白茅根以1:18-30之固液重量比例與水混合,在50-100℃下滅菌萃取0.5-3小時,以獲得白茅根水萃取物,該白茅根水萃取物冷卻至室溫供後續二段式發酵使用,首先殖入0.01-0.5%(v/v)酵母菌(Saccharomyces cerevisiae,購買於生物資源保存與研究中心,台灣,編號為BCRC20271)於該白茅根水萃取物內於20-37℃進行發酵1-3天後,接著直接加入0.01-0.25%(v/v)乳酸桿菌(Lactobacillus plantarum TCI028,專利寄存於生物資源保存與研究中心,台灣,編號為BCRC910805)於20-37℃發酵1-3天;其中,乳酸桿菌TCI028係已於中華民國專利申請號106145146完成專利寄存,此二種菌之發酵依序為:酵母菌、及乳酸桿菌,且無法前後對調,最後在不移除此二種菌之情況下,使用設定的糖度範圍35~45°、pH2~4、酒精<3%等規格,如檢驗符合該規格,則判定發酵完成並得到發酵液,其總多糖含量至少佔20%。接著將發酵液進行高溫滅菌,將該發酵液於45-70℃進行減壓濃縮,並以200-400mesh網篩過濾,再0.5-1.5%之防腐劑(Phenoxyethanol)調整規格後滅菌,即得到本發明之白茅根發酵物,其中藉由微生物發酵製成,使白茅根之效性物質大量釋出。 In an embodiment of the present invention, the roots of Rhizoma Imperatae are thoroughly washed, and the washed Rhizoma Imperatae is mixed with water at a solid-liquid weight ratio of 1:18-30 and sterilized and extracted at 50-100°C for 0.5-3 hours to Obtained the water extract of Phellodendron chinense, which was cooled to room temperature for subsequent two-stage fermentation. First, 0.01-0.5% (v/v) yeast ( Saccharomyces cerevisiae ) was planted and purchased for biological resource preservation and research Center, Taiwan, No. BCRC20271) After fermenting in the water extract of Phellodendron chinense at 20-37°C for 1-3 days, then directly add 0.01-0.25% (v/v) Lactobacillus plantarum TCI028, patent custody At the Center for Biological Resources Conservation and Research, Taiwan, numbered BCRC910805), fermented at 20-37°C for 1-3 days; of which, the Lactobacillus TCI028 series has been patented at Republic of China Patent Application No. 106145146, and the fermentation of these two strains is in order It is: yeast and lactobacilli, which cannot be adjusted back and forth. Finally, without removing these two bacteria, use the set sugar content range of 35~45°, pH2~4, alcohol <3% and other specifications, if the inspection meets With this specification, it is judged that the fermentation is completed and the fermentation broth is obtained, and its total polysaccharide content accounts for at least 20%. Next, the fermentation broth is sterilized at high temperature, the fermentation broth is concentrated under reduced pressure at 45-70°C, and filtered through a 200-400mesh mesh screen, and then adjusted by 0.5-1.5% preservative (Phenoxyethanol) and then sterilized to obtain this product. The invented fermented pakchoi root is made by microbial fermentation, so that the effective substance of pakchoi root is released in large quantities.
本實施例為了比較本發明之白茅根發酵物中總多糖含量是否較白茅根水萃取物高,因此使用苯酚-硫酸法(Phenol-sulfuric acid assay)來定量樣品中總多糖的濃度,其中當糖類遇到強酸時,結構式上的羥基會與酚結合,並 產生橘黃色液體,因此可用比色法(特別是樣品於490nm之吸光值)檢測其中之總多糖的濃度。首先,精密秤取10mg之D-葡萄糖(D-Glucose,購自J.T.Baker,美國,編號為1916-01)置於10mL之容量瓶中,再加入ddH2O至總體積達10mL,並完成D-葡萄糖之標準品(D-Glucose stock,1mg/mL),接著將上述標準品以表一之配方進行系列稀釋,以dd H2O稀釋為0μg/mL、20μg/mL、50μg/mL、100μg/mL、150μg/mL、及200μg/mL之D-Glucose。另外,取1.25g之Phenol(購自Merck,德國,編號1.00206.0250)於容量瓶中,再加入ddH2O至總體積達25mL,以完成5% Phenol的作用溶液。 In this embodiment, in order to compare whether the content of total polysaccharide in the fermented Pakchoi root of the present invention is higher than that of the water extract of Pakchoi root, the Phenol-sulfuric acid assay is used to quantify the concentration of total polysaccharide in the sample. When encountering a strong acid, the hydroxyl group in the structural formula will combine with phenol and produce an orange-yellow liquid, so the colorimetric method (especially the absorbance of the sample at 490nm) can be used to detect the concentration of the total polysaccharide. First, accurately weigh 10 mg of D-glucose (D-Glucose, purchased from JTBaker, USA, number 1916-01) into a 10 mL volumetric flask, then add ddH 2 O to a total volume of 10 mL, and complete D- Glucose standard product (D-Glucose stock, 1 mg/mL), then serially dilute the above standard product according to the formula in Table 1, and dilute with dd H 2 O to 0 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/ mL, 150μg/mL, and 200μg/mL of D-Glucose. In addition, 1.25g of Phenol (purchased from Merck, Germany, No. 1.0206.0250) was taken into a volumetric flask, and then ddH 2 O was added to a total volume of 25mL to complete a 5% Phenol solution.
接著繪製標準溶液之迴歸曲線,取各濃度之標準溶液100μL於玻璃試管中,分別加入500μL之5% Phenol溶液,並緩慢地加入2.5mL硫酸溶液(95.5%之H2SO4,購自Showa,日本,編號1970-5250)於各試管中,以Vortex混合均勻後靜置20分鐘,接著取200μL各組混合液於96孔培養盤中,測量於490nm之吸光值,以繪製標準溶液之迴歸曲線公式。接著,分別取100μL之白茅根水萃取物、及本發明之白茅根發酵物於玻璃試管中,分別加入500μL之5% Phenol溶液,並緩慢地加入2.5mL硫酸溶液於各試管中,以Vortex混合均勻後靜置20分鐘,接著取200μL各組混合液於96孔培養盤中,測量於490nm之吸光值,並以上述之標準溶液的迴歸曲線公式,以內差法算出濃度後再回乘稀釋倍數以取得原白茅根水萃取物及本發明之白茅根發酵物中總多糖之濃度。 Then draw the regression curve of the standard solution, take 100 μL of each standard solution in a glass test tube, add 500 μL of 5% Phenol solution, and slowly add 2.5 mL of sulfuric acid solution (95.5% H 2 SO4, purchased from Showa, Japan , No. 1970-5250) In each test tube, mix with Vortex and let stand for 20 minutes, then take 200μL of each group of mixed solution in a 96-well culture dish and measure the absorbance at 490nm to draw the regression curve formula of the standard solution . Next, take 100 μL of Pakchoi root water extract and the Pakchoi root fermentation product of the present invention in glass test tubes, respectively add 500 μL of 5% Phenol solution, and slowly add 2.5 mL of sulfuric acid solution to each test tube, mix with Vortex After homogenization, let stand for 20 minutes, then take 200μL of each group of mixed solution in a 96-well culture dish, measure the absorbance at 490nm, and use the regression curve formula of the above standard solution to calculate the concentration by the internal difference method and then multiply the dilution factor In order to obtain the concentration of total polysaccharides in the raw water extract of Pakchoi root and the fermented Pakchoi root of the present invention.
本發明之白茅根發酵物中總多糖含量上升之結果如圖2所示。白茅根經本發明之二段式發酵作用後,其中總多糖含量較單純之白茅根水萃取物高出21%,此結果顯示本發明之白茅根發酵物在經過本發明微生物發酵步驟後,可有效提升其中的總多糖含量,該發酵步驟能提升皮膚保濕的功效,並提升皮膚角質層結構之完整。 The result of the increase in the total polysaccharide content in the fermented Pakchoi root of the present invention is shown in FIG. 2. After the two-stage fermentation of the present invention, the total polysaccharide content of Pakchoi root is 21% higher than that of the pure Pakchoi root water extract. This result shows that the pakchoi root fermented product of the present invention can be effective after the microbial fermentation step of the present invention. To increase the total polysaccharide content, this fermentation step can enhance the skin's moisturizing effect and enhance the integrity of the skin's stratum corneum structure.
本發明以人類初代皮膚角質細胞(human primary epidermal keratinocytes,HPEK)進行本發明之白茅根發酵物調控TGM1基因、KRT1基因、KRT10基因、KRT14基因、AQP3基因、FLG基因、HAS2基因、及HAS3基因表現量之分析。該人類初級皮膚角質細胞購自CELLnTEC公司(瑞士)編號HPEK-50,將該細胞培養於無血清之角質細胞培養液(keratinocyte-SFM)(Gibco公司,編號為#17005042,美國),並於含有5% CO2之37℃細胞培養箱中進行培養。 The present invention uses human primary epidermal keratinocytes (HPEK) to perform expression of TGM1 gene, KRT1 gene, KRT10 gene, KRT14 gene, AQP3 gene, FLG gene, HAS2 gene, and HAS3 gene expression of Pakchoi root fermented material of the present invention. Quantitative analysis. The human primary skin keratinocytes were purchased from CELLnTEC (Switzerland) No. HPEK-50, and the cells were cultured in serum-free keratinocyte-SFM (Gibco, No. #17005042, United States), and contained Incubate in a 37°C cell incubator with 5% CO 2 .
將1.5×105個HPEK-50細胞培養於含有2mL上述細胞培養液之六孔培養盤中,於37℃培養24小時後,在不干擾貼附之細胞的情況下移除培養液,接著將細胞分成以下三組:(1)僅含有細胞培養液之控制組、(2)加入0.125%白茅根水萃取物之比較組、及(3)加入0.125%本發明之白茅根發酵物的實驗組分別作用6小時,接著將角質細胞以細胞裂解液(RB buffer,購自Geanaid公司,臺灣,Cat No.RBD300)回收細胞後,使用RNA萃取試劑套組(購自Geneaid公司,臺灣,Cat No.RBD300)分別收集兩組細胞內之RNA,接著利用SuperScript® III反轉錄酶(購自Invitrogene公司,美國,編號18080-051)以2000ng之萃取RNA為模板並以引子產生mRNA反轉錄之相應cDNA產物,接著利用ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國),以及KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)將兩組反轉錄後產物分別以表二之組合引子進行定量即時反轉錄聚合酶連鎖反應(quantitative real-time reverse transcription polymerase chain reaction)試驗,條件為95℃反應1秒,60℃反應20秒,總共40個迴圈。用以定量TGM1基因、KRT1基因、KRT10基因、KRT14基因、AQP3基因、FLG基因、HAS2基因、及HAS3基因之mRNA表現量,其中定量數值係取由閾值循環數(Ct),而目標基因的mRNA相對量係推導自方程式2-△Ct,其中△Ct=Ct目標基因-CtACTB(β-肌動蛋白,beta-actin),再利用Excel軟體進行非成對單尾student t-test以決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 1.5×10 5 HPEK-50 cells were cultured in a six-well culture dish containing 2 mL of the above cell culture solution. After culturing at 37° C. for 24 hours, the culture solution was removed without disturbing the attached cells, and then the The cells are divided into the following three groups: (1) a control group containing only cell culture fluid, (2) a comparative group with 0.125% of Pakchoi root water extract, and (3) an experimental group with 0.125% of Pakchoi root fermented material of the present invention After 6 hours of operation, the keratinocytes were recovered in cell lysate (RB buffer, purchased from Geanaid, Taiwan, Cat No. RBD300), and then used RNA extraction reagent kit (purchased from Geneaid, Taiwan, Cat No. (RBD300) Collect RNA in two groups of cells separately, and then use SuperScript ® III reverse transcriptase (purchased from Invitrogene, USA, No. 18080-051) to extract RNA with 2000 ng as a template and use primers to generate corresponding cDNA products for reverse transcription of mRNA Then, use ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific, USA), and KAPA SYBR FAST (purchased from Sigma, USA, No. 38220000000) to carry out the two sets of reverse transcription products using the combination primers in Table 2 Quantitative real-time reverse transcription polymerase chain reaction (quantitative real-time reverse transcription polymerase chain reaction) test, the conditions are 95 ℃ for 1 second, 60 ℃ for 20 seconds, a total of 40 cycles. Used to quantify the mRNA expression of TGM1 gene, KRT1 gene, KRT10 gene, KRT14 gene, AQP3 gene, FLG gene, HAS2 gene, and HAS3 gene, where the quantitative value is taken from the threshold cycle number (Ct), and the target gene mRNA The relative quantity system is derived from Equation 2 -△Ct , where △Ct=Ct target gene- Ct ACTB (β-actin, beta-actin), and then use Excel software to perform unpaired single-tailed student t-test to determine the mutation The coefficient is statistically significantly different (*p value <0.05; **p value <0.01; ***p value <0.001).
本發明之白茅根發酵物提升KRT14基因、FLG基因、HAS2基因、及HAS3基因表現量之結果如圖2所示。先前研究指出TGM會使角質化細胞之細胞膜與結構蛋白間形成強力鍵結,並能增加表皮層的強度與穩定性;KRT會形成角蛋微絲,而FLG會幫助角蛋白微絲組裝成堅固的網絡,為皮膚提供強度和彈性;AQP則會加角質細胞內水的通透性,以提高角質細胞的含水量;HAS會促進角質細胞分泌玻尿酸的能力,並使皮膚角質層結構完整且提升皮膚屏障功能,能使皮膚保水力提升,其中提升AQP基因及HAS基因的表現量,特別是HAS基因,能夠有效使角質細胞分泌更多保濕因子。 The results of enhancing the expression level of KRT14 gene, FLG gene, HAS2 gene, and HAS3 gene by the fermented material of Phellodendron chinense in the present invention are shown in FIG. 2. Previous studies have pointed out that TGM will form strong bonds between the cell membrane of keratinocytes and structural proteins, and can increase the strength and stability of the epidermal layer; KRT will form keratin egg filaments, and FLG will help keratin filaments assemble into a strong The network provides strength and elasticity to the skin; AQP will increase the permeability of water in the keratinocytes to increase the water content of the keratinocytes; HAS will promote the ability of the keratinocytes to secrete hyaluronic acid, and complete and enhance the structure of the skin horny layer The skin barrier function can improve the skin's water retention capacity. Among them, the expression level of AQP gene and HAS gene, especially HAS gene, can effectively make keratinocytes secrete more moisturizing factors.
人類初代角質細胞經本發明之白茅根發酵物處理後,KRT14基因表現量較控制組高約1.2倍、FLG基因表現量較控制組高約1.4倍、HAS2基因表現量較控制組顯著的高約1.5倍、及HAS3基因表現量較控制組高約1.2倍,且KRT14基因、FLG基因、HAS2基因及HAS3基因的表現量皆較比較組為高;另外,TGM1基因、KRT1基因、KRT10基因、及AQP3基因則與控制組差異不大,此結果顯示本發明之白茅根發酵物在經過微生物發酵步驟後,可藉由有效提高KRT14基因、FLG基因、HAS2基因及HAS3基因的表現量,而有效能使皮膚角質分泌更多保濕因子,並使皮膚保濕能力上升、維持角質細胞排列、維持角質層結構完整,以提升皮膚屏障功能。 After the primary human keratinocytes were treated with the fermented Pakchoi root of the present invention, the KRT14 gene expression was about 1.2 times higher than the control group, the FLG gene expression was about 1.4 times higher than the control group, and the HAS2 gene expression was about 1.5 times higher than the control group. times, and HAS3 expression levels of genes than the control group a height of about 1.2 times, and KRT14 gene, the FLG gene, the HAS2 gene, and expression levels of HAS3 genes of both than comparative group is high; Further, TGM1 gene, KRT1 gene, KRT10 gene, The AQP3 gene is not much different from the control group. This result shows that the fermented Pakchoi root of the present invention can effectively increase the expression of the KRT14 gene, FLG gene, HAS2 gene and HAS3 gene after the microbial fermentation step. It can make the skin keratin secret more moisturizing factors, and increase the skin's moisturizing ability, maintain the arrangement of keratinocytes, maintain the integrity of the stratum corneum structure, and enhance the skin barrier function.
本發明實施例以人類皮膚纖維母細胞(Human skin fibroblast,CCD-966sk)進行本發明之白茅根發酵物於促進膠原蛋白增生之分析。該人類皮膚纖維母細胞購自美國典型培養物保藏中心(ATCC®),編號CRL-1881,將該細胞培養於含有10%之胎牛血清(Fetal Bovine Serum)以及90%之Minimum Essential Medium(MEM)的培養液(購自Gibco,美國),其中含有1mM之丙酮酸鈉(Sodium pyruvate)以及1%之青黴素/鏈黴素(penicillins/streptomycin)。 In the embodiment of the present invention, human skin fibroblast (CCD-966sk) is used to analyze the fermented matter of Phellodendron chinense in promoting collagen hyperplasia. The human skin fibroblasts were purchased from the American Type Culture Collection (ATCC®), number CRL-1881, and the cells were cultured in 10% fetal bovine serum (Fetal Bovine Serum) and 90% Minimum Essential Medium (MEM ) Culture medium (purchased from Gibco, USA), which contains 1 mM sodium pyruvate and 1% penicillins/streptomycin.
首先,將2×104個人類皮膚纖維母細胞種植於含500μL之上述培養液之24孔培養盤中,並於37℃培養24小時後,以1倍磷酸鹽緩衝溶液(1xPhosphate buffered saline,1xPBS)在不擾動細胞之情況下沖洗細胞,接著將細胞分成以下二組:(1)加入0.125%白茅根水萃取物之比較組、及(2)加入0.125%本發明之白茅根發酵物的實驗組,分別溶於500μL不含胎牛血清之MEM,並以沒有加入任何萃取物之組別為空白控制組,以及僅含有培養液不含細胞之組別以作為後續讀取吸光值之背景值,於37℃培養48小時後,在不擾動細胞之情況下,每組細胞收集1mL之培養液,並置於1.5mL離心管中,以可溶性膠原蛋白分析套組(SircolTM Soluble Collagen Assay kit,Bicolor Life Science Assays,Notherm Ireland,英國),檢測皮膚纖維母細胞分泌之膠原蛋白的量。首先加入200μL之膠原蛋白分離與濃縮試劑(collagen isolation & concentration reagent)並上下倒置6-8次以混合均勻,接著將離心管於4℃放置16-18小時,時間到後取出,避免搖晃到管身,並在4℃下以12000rpm離心10分鐘,離心後小心地移除1mL之上清液,再加入1mL之Sircol染劑(Sircol dye reagent)使膠原蛋白染色,並輕柔地搖晃30分鐘以混合均勻,接著在4℃下以12000rpm離心10分鐘後移除上清液,再加入750μL酸性鹽清洗劑(Acid-salt washing reagent),以將多餘的染劑清洗掉,並在4℃下以12000rpm離心10分鐘後移除上清液,並小心地以棉球將殘留於管壁及蓋子的液體移除,接著加入250μL之強鹼試劑(alkali reagent)並以 試管震盪器使膠原蛋白均勻溶解,最後以酵素免疫分析儀(ELISA reader,BioTek)測量此各組及空白控制組之產物於555nm之吸光值,並於扣除背景值後,計算該各組之讀值與空白控制組之差異的百分比,再以Excel軟體進行student t-test以決定變異係數與是否在統計上具有顯著差異(與空白控制組比較:*p值<0.05;**p值<0.01;***p值<0.001。與白茅根水萃取物比較:#p值<0.05;##p值<0.01;###p值<0.001)。 First, 2×10 4 human dermal fibroblasts were planted in a 24-well culture dish containing 500 μL of the above-mentioned culture solution, and after incubation at 37° C. for 24 hours, with 1x Phosphate buffered saline, 1xPBS ) Rinse the cells without disturbing the cells, and then divide the cells into the following two groups: (1) a comparison group added with 0.125% Pakchoi root water extract, and (2) an experiment with 0.125% Pakchoi root fermented substance of the present invention Groups were dissolved in 500 μL of MEM without fetal bovine serum, and the group without any extract added was used as a blank control group, and the group containing only culture medium without cells was used as the background value for subsequent reading of absorbance. After incubating for 48 hours at 37°C, without disturbing the cells, collect 1 mL of culture solution in each group of cells and place it in a 1.5 mL centrifuge tube. Use the soluble collagen analysis kit (Sircol TM Soluble Collagen Assay kit, Bicolor Life Science Assays, Notherm Ireland, United Kingdom), to detect the amount of collagen secreted by skin fibroblasts. First add 200μL of collagen isolation & concentration reagent (collagen isolation & concentration reagent) and invert upside down 6-8 times to mix evenly, then place the centrifuge tube at 4℃ for 16-18 hours, take out after the time is up, avoid shaking to the tube Centrifuge at 12000rpm for 10 minutes at 4°C. After centrifugation, carefully remove 1mL of supernatant, add 1mL of Sircol dye reagent (Sircol dye reagent) to stain collagen, and gently shake for 30 minutes to mix Homogenize, then centrifuge at 12000 rpm for 10 minutes at 4°C, remove the supernatant, and then add 750 μL of acid-salt washing reagent to wash away excess dye, and at 12,000 rpm at 4°C After centrifuging for 10 minutes, remove the supernatant, and carefully remove the liquid remaining on the tube wall and lid with a cotton ball. Then add 250 μL of strong alkali reagent (alkali reagent) and dissolve the collagen evenly with a test tube shaker. Finally, the absorbance value of the products of each group and the blank control group at 555 nm is measured with an enzyme immunoassay analyzer (ELISA reader, BioTek), and after deducting the background value, the percentage of the difference between the reading value of each group and the blank control group is calculated Then, student t-test is performed in Excel software to determine whether the coefficient of variation is statistically significant (compared with the blank control group: *p value <0.05; **p value <0.01; ***p value <0.001. Compared with the water extract of Phellodendron amurense: #p value <0.05;##p value <0.01;###p value <0.001).
本發明之白茅根發酵物於促進皮膚細胞中膠原蛋白增生之實驗結果如圖3所示。人類初代角質細胞經本發明之白茅根發酵物處理後之實驗組,較空白控制組顯著高出23%之膠原蛋白含量,以白茅根水萃取物處理之比較組僅較空白控制組高出2%,其中實驗組亦與比較組具有顯著差異性。此結果顯示本發明之白茅根發酵物在經過微生物發酵步驟後,能有效促進皮膚細胞的膠原蛋白增生,並能使皮膚恢復光滑緊致,以提升皮膚飽水量以使皮膚豐盈細滑。 The experimental results of the fermented chrysanthemum root of the present invention in promoting the proliferation of collagen in skin cells are shown in FIG. 3. The experimental group of human primary keratinocytes treated with the fermented Pakchoi root of the present invention had a collagen content significantly higher than that of the blank control group by 23%, and the comparison group treated with Pakchoi root water extract was only 2% higher than the blank control group Among them, the experimental group and the comparative group also have significant differences. This result shows that the fermented chrysanthemum root fermented product of the present invention can effectively promote the collagen proliferation of skin cells after the microbial fermentation step, and can restore the skin to be smooth and firm, so as to increase the saturated amount of skin to make the skin plump and smooth.
本發明實施例以人類皮膚纖維母細胞(Human skin fibroblast,CCD-966sk)進行本發明之白茅根發酵物於促進彈力蛋白增生之分析。該人類皮膚纖維母細胞購自美國典型培養物保藏中心(ATCC®),編號CRL-1881,將該細胞培養於含有10%之胎牛血清(Fetal Bovine Serum)以及90%之Minimum Essential Medium(MEM)的培養液(購自Gibco,美國),其中含有1mM之丙酮酸鈉(Sodium pyruvate)以及1%之青黴素/鏈黴素(penicillins/streptomycin)。 In the embodiment of the present invention, human skin fibroblast (CCD-966sk) is used to analyze the fermented matter of Pakchoi root of the present invention to promote elastin proliferation. The human skin fibroblasts were purchased from the American Type Culture Collection (ATCC®), number CRL-1881, and the cells were cultured in 10% fetal bovine serum (Fetal Bovine Serum) and 90% Minimum Essential Medium (MEM ) Culture medium (purchased from Gibco, USA), which contains 1 mM sodium pyruvate and 1% penicillins/streptomycin.
首先,將1×105個人類皮膚纖維母細胞種植於含2mL之上述培養液之6孔培養盤中,並於37℃培養24小時後,以磷酸鹽緩衝溶液(Phosphate buffered saline,PBS)在不擾動細胞之情況下沖洗細胞,接著將細胞分成以下二
組:(1)加入0.125%白茅根水萃取物之比較組、及(2)加入0.125%本發明之白茅根發酵物的實驗組,分別溶於2mL不含胎牛血清之MEM,並以沒有加入任何萃取物之組別為空白控制組,以及僅含有培養液不含細胞之組別以作為後續讀取吸光值之背景值,將上述各組細胞於37℃培養48小時後,在不擾動細胞之情況下移除培養液並以1xPBS清洗細胞一次,接著加入200μL胰蛋白酶(Trypsin)反應3分鐘,使細胞由培養盤上脫落,加入1mL之細胞培養液終止反應,並將細胞連同培養液收集至1.5mL試管,並以300g離心5分鐘後移除上清液,並以1xPBS清洗細胞一次後,再以300g離心5分鐘後移除上清液,並加入約300μL之1xPBS重新懸浮細胞,接著以彈性蛋白分析套組(FastinTM Elastin Assay kit,購自Biocolor,英國),檢測皮膚纖維母細胞分泌之彈性蛋白的量。首先加入100μL之1.0M草酸溶液,並置於100℃之加熱板上作用1小時,接著於各管中加入與管內溶液相同體積之彈性蛋白沉澱試劑(Elastin Precipitating Reagent),關緊上蓋後以vortex充分混合均勻,並靜置15分鐘使彈性蛋白完全沉澱,接著10,000g離心10分鐘後,將離心管中的液體排空,並將離心管倒置且在紙巾上輕敲,使移除管中大部分之剩餘液體,接著加入1mL的TPPS(5,10,15,20-tetraphenyl-21H,23H-porphine tetra-sulfonate)染料試劑,並將離心管上下倒置數次以混合均勻後置於機械振盪器上設定6rpm反應90分鐘,移除未結合之染劑,其中在離心管的底部和可觀察到彈性蛋白-染劑複合物(elastin-dye complex)之紅褐色沉澱物,接著於各管中加入250μL之染料解離試劑(Dye Dissociation Reagent),關緊上蓋後以vortex充分混合使染劑釋放到溶液中,以確保所有結合之染劑已進入溶液中,再將各管之內容物轉移至96孔培養盤中,並以酵素免疫分析儀(ELISA reader,BioTek)測量此各組及空白控制組之產物於513nm之吸光值,並於扣除背景值後,計算該各組之讀值與空白控制組之差異的百分比,再以Excel軟體進行student t-test以決定變異係數與是否在統計上具有顯著差異(與空白控制組比
較:*p值<0.05;**p值<0.01;***p值<0.001。與白茅根水萃取物比較:#p值<0.05;##p值<0.01;###p值<0.001)。
First,
本發明之白茅根發酵物於促進皮膚細胞中彈力蛋白增生之實驗結果如圖4所示。人類初代角質細胞經本發明之白茅根發酵物處理後之實驗組,較空白控制組顯著高出34%之彈力蛋白含量,以白茅根水萃取物處理之比較組僅較空白控制組高出約2%,其中實驗組亦與比較組具有顯著差異性。此結果顯示本發明之白茅根發酵物在經過微生物發酵步驟後,能有效促進皮膚細胞的彈力蛋白增生,並能維持皮膚緊實有彈性,以減少皮膚的皺紋產生使皮膚豐盈細滑。 The experimental results of the fermented chrysanthemum root of the present invention in promoting elastin proliferation in skin cells are shown in FIG. 4. The experimental group of human primary keratinocytes treated with Pakchoi root fermented material of the present invention had significantly higher elastin content of 34% than the blank control group. The comparison group treated with Pakchoi root water extract was only about 2 higher than the blank control group %, of which the experimental group is also significantly different from the comparison group. This result shows that the fermented chrysanthemum root fermented product of the present invention can effectively promote the proliferation of elastin of skin cells after the microbial fermentation step, and can maintain the skin firm and elastic, so as to reduce the generation of wrinkles and make the skin plump and smooth.
本發明實施例以人類皮膚纖維母細胞(Human skin fibroblast,CCD-966sk)進行本發明之白茅根發酵物於提升細胞抗氧化能力之分析。該人類皮膚纖維母細胞購自美國典型培養物保藏中心(ATCC®),編號CRL-1881。該細胞係培養於90%含有0.1mM之非必需氨基酸、1.5g/L之碳酸氫鈉及1mM丙酮酸鈉之MEM(Minimum essential medium,購自Eagle,美國,編號61100-061)細胞培養液中,其中含有10%之胎牛血清(Fetal Bovine Serum,購自Gibco,美國)。 In the embodiment of the present invention, human skin fibroblast (CCD-966sk) is used to analyze the fermented matter of Phellodendron chinense in the invention to enhance the antioxidant capacity of the cell. The human skin fibroblasts were purchased from the American Type Culture Collection (ATCC®), number CRL-1881. The cell line was cultured in 90% MEM (Minimum essential medium, purchased from Eagle, USA, No. 6100-061) cell culture medium containing 0.1 mM of non-essential amino acids, 1.5 g/L of sodium bicarbonate and 1 mM sodium pyruvate , Which contains 10% fetal bovine serum (Fetal Bovine Serum, purchased from Gibco, USA).
將2×105個CCD-966sk細胞培養於含有2mL上述細胞培養液之6孔培養盤中,於37℃培養24小時後,在不干擾貼附之細胞的情況下移除培養液,接著將細胞分成以下四組(每組n=2):(1)僅加入細胞培養液作用2小時之空白控制組、(2)加入1mM之H2O2(購自Sigma,美國,原液濃度為35%)之正控制組、(3)同時加入1mM之H2O2及白茅根水萃取物之比較組、及(4)同時加入1mM之H2O2及本發明之白茅根發酵物之實驗組,其中第(2)組、第(3)組、及第(4)組皆於37℃下反應1小時。接著各組分別加入5μg/mL之DCFH-DA於37℃處理15分鐘,再以H2O2於37℃處理細胞1小時後,以1mL之1xPBS清洗細胞兩次,並 加入200μL胰蛋白酶在黑暗中反應5分鐘,使細胞由培養盤上脫落,加入適當的培養液終止反應,並將細胞連同培養液收集至1.5mL離心管,以400g離心10分鐘後移除上清液,再以1mL之1xPBS沖洗細胞一次後,並於400g離心10分鐘後除上清液,接著以1mL之1xPBS重新懸浮細胞,並加入DCFH-DA(購自Sigma,美國,編號SI-D6883-50MG,5mg/mL保存於DMSO中)標記細胞,並使用流式細胞儀檢測細胞於激發波長450-490nm、放射波長510-550nm的螢光數值,計算含有螢光訊號之細胞數。再利用Excel軟體進行student t-test以決定兩個樣本群體之間是否在統計上具有顯著差異(與空白控制組比較:*p值<0.05;**p值<0.01;***p值<0.001。與白茅根水萃取物比較:#p值<0.05;##p值<0.01;###p值<0.001)。 2×10 5 CCD-966sk cells were cultured in a 6-well culture dish containing 2 mL of the above-mentioned cell culture fluid. After culturing at 37° C. for 24 hours, the culture fluid was removed without disturbing the attached cells, and then the The cells were divided into the following four groups (n=2 for each group): (1) blank control group with cell culture medium added for 2 hours, (2) 1 mM H 2 O 2 (purchased from Sigma, USA, stock solution concentration 35) %) positive control group, (3) a comparative group with 1 mM H 2 O 2 and water extract of Pakchoi root simultaneously, and (4) an experiment with 1 mM H 2 O 2 and fermented Pakchoi root of the present invention Group, of which group (2), group (3), and group (4) were all reacted at 37°C for 1 hour. Then each group was added with 5 μg/mL of DCFH-DA at 37°C for 15 minutes, and then treated with H 2 O 2 at 37°C for 1 hour, then washed the cells twice with 1 mL of 1xPBS, and added 200 μL of trypsin in the dark After 5 minutes of reaction, the cells are detached from the culture plate. Add appropriate culture medium to stop the reaction. Collect the cells and culture medium into a 1.5 mL centrifuge tube. Centrifuge at 400 g for 10 minutes to remove the supernatant. After washing the cells once with 1xPBS, centrifuging at 400g for 10 minutes, removing the supernatant, then resuspending the cells with 1mL of 1xPBS and adding DCFH-DA (purchased from Sigma, USA, number SI-D6883-50MG, 5mg/mL) In DMSO) label the cells, and use flow cytometry to detect the fluorescence values of the cells at the excitation wavelength of 450-490nm and the emission wavelength of 510-550nm, and calculate the number of cells containing the fluorescent signal. Then use Excel software to conduct student t-test to determine whether there are statistically significant differences between the two sample groups (compared with the blank control group: *p value <0.05; **p value <0.01; ***p value< 0.001. Compared with the water extract of Phellodendron chinense: #p value<0.05;##pvalue<0.01;###pvalue<0.001).
Dichloro-dihydro-fluorescin diacetate(DCFH-DA)是一種穩定的非極性化合物,可自由通透細胞膜,當DCFH-DA進入細胞後,會被細胞內的脂質酶水解,形成具有極性的DCFH,停留在細胞內無法出來,並會細胞內的活性氧類物質(Reactive Oxygen Species,簡稱ROS)與DCFH產生氧化還原反應形成Dichloro-fluorescin(DCF),以450-490nm波長激發後,會產生的綠色螢光可以被於510-550nm波長被偵測出,因此偵測經DCFH-DA處理之細胞的螢光強度,能反映細胞內活性氧物質之含量。 Dichloro-dihydro-fluorescin diacetate (DCFH-DA) is a stable non-polar compound that can freely penetrate the cell membrane. When DCFH-DA enters the cell, it will be hydrolyzed by the lipase in the cell to form polar DCFH and stay in Reactive Oxygen Species (ROS) and DCFH produce redox reaction to form Dichloro-fluorescin (DCF), which will produce green fluorescence after excitation at 450-490nm wavelength It can be detected at a wavelength of 510-550nm, so detecting the fluorescence intensity of cells treated with DCFH-DA can reflect the content of reactive oxygen species in the cells.
本發明之白茅根發酵物於提升細胞抗氧化能力之實驗結果如圖5所示,其中以空白控制組所測得之螢光數值作為0%、以經H2O2處理之正控制組所測得之螢光數值為100%。人類初代角質細胞經本發明之白茅根發酵物處理後之實驗組,能顯著減少15%之ROS含量,以白茅根水萃取物處理之比較組僅能減少約3.5%,其中實驗組亦與比較組具有顯著差異性。此結果顯示本發明之白茅根發酵物在經過微生物發酵步驟後,能有效清除皮膚細胞中的自由基,能提升皮膚細胞抗氧化能力,以防止皮膚老化的發生。 The experimental results of the fermented material of Phellodendron arundinaceum in the present invention to improve the antioxidant capacity of cells are shown in FIG. 5, wherein the fluorescence value measured by the blank control group is taken as 0%, and the positive control group treated with H 2 O 2 is used The measured fluorescence value is 100%. The experimental group of human primary keratinocytes treated with the fermented Pakchoi root of the present invention can significantly reduce the ROS content by 15%. The comparative group treated with the water extract of Pakchoi root can only reduce about 3.5%, among which the experimental group is also compared with the comparative group There are significant differences. This result shows that the fermented chrysanthemum root fermentation product of the present invention can effectively remove free radicals in skin cells after the microorganism fermentation step, and can enhance the antioxidant capacity of skin cells to prevent the occurrence of skin aging.
綜上所述,本發明之白茅根發酵物在經過微生物發酵步驟後,能有效提升其中效性成分總多糖的含量,以提升皮膚保濕的功效,並提升皮膚角質層結構之完整;亦能藉由有效提高KRT14基因、FLG基因、HAS2基因及HAS3基因的表現量,而有效使皮膚角質分泌更多保濕因子,並使皮膚保濕能力上升、維持角質細胞排列、維持角質層結構完整,以提升皮膚屏障功能;亦能有效促進皮膚細胞的膠原蛋白增生,並能使皮膚恢復光滑緊致,以提升皮膚飽水度使皮膚豐盈細滑;亦能有效促進皮膚細胞的彈力蛋白增生,以維持皮膚緊實有彈性,並減少皮膚的皺紋產生使皮膚豐盈細滑;以及能有效清除皮膚細胞中的自由基,能提升皮膚細胞抗氧化能力,以防止皮膚老化的發生。因此,本發明之白茅根發酵物可用於製備提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力之組合物的用途,該組合物該組合物是一醫藥品、一食品或一保養品,可藉由口服、皮膚塗抹等方式給予一個體。 In summary, after fermented by microbial fermentation, the fermented chrysanthemum root of the present invention can effectively increase the content of the total polysaccharide in the active ingredient, so as to enhance the moisturizing effect of the skin, and enhance the integrity of the skin stratum corneum structure; Effectively improve the expression of KRT14 gene, FLG gene, HAS2 gene and HAS3 gene, and effectively make the skin keratin secret more moisturizing factors, and increase the skin's moisturizing ability, maintain the arrangement of keratinocytes, and maintain the integrity of the stratum corneum to enhance the skin Barrier function; It can also effectively promote the collagen proliferation of skin cells, and can restore skin smoothness and firmness, so as to increase skin saturation and make the skin plump and smooth; it can also effectively promote the proliferation of elastin of skin cells to maintain skin tightness It is elastic and reduces the generation of wrinkles on the skin to make the skin plump and smooth; and it can effectively remove free radicals in skin cells and enhance the antioxidant capacity of skin cells to prevent skin aging. Therefore, the fermented roots of the present invention can be used to prepare a composition for enhancing the expression of skin keratin gene, polykeratin filament gene and hyaluronic acid synthase gene, promoting the proliferation of collagen and elastin, and enhancing the antioxidant capacity Use, the composition The composition is a medicinal product, a food or a care product, and can be administered to a body by oral administration, skin application, or the like.
<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.
<120> 白茅根發酵物用於提升皮膚細胞角蛋白基因、聚角蛋白微絲基因與玻尿酸合成酶基因表現量、促進膠原蛋白與彈力蛋白增生、及提升抗氧化能力的用途 <120> The ferment of Pakchoi root is used to enhance the expression of skin keratin gene, polykeratin microfilament gene and hyaluronic acid synthase gene, promote the proliferation of collagen and elastin, and enhance the antioxidant capacity
<130> 107B0475-I1 <130> 107B0475-I1
<160> 18 <160> 18
<170> PatentIn version 3.5 <170> PatentIn version 3.5
<210> 1 <210> 1
<211> 22 <211> 22
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 1 <400> 1
<210> 2 <210> 2
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 2 <400> 2
<210> 3 <210> 3
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 3 <400> 3
<210> 4 <210> 4
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 4 <400> 4
<210> 5 <210> 5
<211> 22 <211> 22
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 5 <400> 5
<210> 6 <210> 6
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 6 <400> 6
<210> 7 <210> 7
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 7 <400> 7
<210> 8 <210> 8
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 8 <400> 8
<210> 9 <210> 9
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 9 <400> 9
<210> 10 <210> 10
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 10 <400> 10
<210> 11 <210> 11
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 11 <400> 11
<210> 12 <210> 12
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 12 <400> 12
<210> 13 <210> 13
<211> 23 <211> 23
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 13 <400> 13
<210> 14 <210> 14
<211> 20 <211> 20
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 14 <400> 14
<210> 15 <210> 15
<211> 19 <211> 19
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 15 <400> 15
<210> 16 <210> 16
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 16 <400> 16
<210> 17 <210> 17
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 17 <400> 17
<210> 18 <210> 18
<211> 21 <211> 21
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic primer
<400> 18 <400> 18
Claims (15)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107140453A TWI674107B (en) | 2018-11-14 | 2018-11-14 | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells |
CN201910449571.6A CN111184822A (en) | 2018-11-14 | 2019-05-27 | Application of cogongrass rhizome fermentation product in improving gene expression quantity, promoting proliferation of collagen and elastin and improving oxidation resistance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107140453A TWI674107B (en) | 2018-11-14 | 2018-11-14 | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI674107B TWI674107B (en) | 2019-10-11 |
TW202017585A true TW202017585A (en) | 2020-05-16 |
Family
ID=69023722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107140453A TWI674107B (en) | 2018-11-14 | 2018-11-14 | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111184822A (en) |
TW (1) | TWI674107B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115350196B (en) * | 2022-10-17 | 2023-02-03 | 山东科金生物发展有限公司 | Biological preparation for reducing skin aging and improving skin injury repair |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09309841A (en) * | 1996-05-20 | 1997-12-02 | Shiseido Co Ltd | Preparation for external use for skin |
KR101303295B1 (en) * | 2011-07-22 | 2013-09-03 | 이상록 | The cosmetic composition for promoting cell growth and recovery of distrupted skin containing the extracts of fermented Mistletoe, fermented Imperata cylindrica and fermented soybean |
KR20160055118A (en) * | 2016-04-29 | 2016-05-17 | 장문식 | Cosmetic composition comprising of the mixed herb fermentes and preparation method of the same |
-
2018
- 2018-11-14 TW TW107140453A patent/TWI674107B/en active
-
2019
- 2019-05-27 CN CN201910449571.6A patent/CN111184822A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN111184822A (en) | 2020-05-22 |
TWI674107B (en) | 2019-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108553403B (en) | A kind of purposes of thermus thermophilus and saccharomycete combined fermentation product | |
US7514092B2 (en) | Compositions and methods of their use for improving the condition and appearance of skin | |
TWI693899B (en) | Fermentation product of punica granatum and uses thereof | |
TWI734474B (en) | Use of annona muricata ferments in the manufacture of a composition for skin tightening, anti-glycation, and gene regulation | |
TWI784229B (en) | Lonicera japonica thunb ferment, preparation method thereof and use thereof for improving skin appearance and anti-aging | |
TWI754189B (en) | Use of protea cynaroides extract for enhancing mitochondrial activity of skin cells | |
TW202014176A (en) | Pachyrhizus erosus fermented extracts and the use thereof for enhancing the gene expression of col, timp, lox, eln, has, sod, tcp1 and ung, and for reducing the skin melanin content | |
TWI737086B (en) | Fermentation method for increasing content of effective components in plants | |
TWI774046B (en) | Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat | |
TWI729618B (en) | Use of phalaenopsis plant extract for anti-glycation and improving skin appearance | |
TWI674107B (en) | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells | |
TW202114631A (en) | Fermentation broth of carica papaya and uses thereof for beautifying skin | |
TWI777096B (en) | Use of extract of ginkgo biloba callus tissue for improving skin redness | |
TWI687237B (en) | Use of extract of victoria cruziana for inducing expression of keratin gene and hyaluronan synthase 2 gene, and enhancing moisture-retaining capacity of skin | |
TWI801770B (en) | Uses of nostoc sphaeroides extract for reducing body fat and enhancing skin appearance | |
TWI776985B (en) | Use of labisia pumila extract for improving skin elasticity, strength or stability | |
WO2024008187A1 (en) | Use of prunus lannesiana extract in preparation of drug for improving skin condition or basal metabolic rate | |
CN114146040A (en) | Composition for strengthening skin barrier and resisting aging as well as preparation method and application thereof | |
TW202313087A (en) | Prunus salicinaferment, manufacturing method thereof, and uses thereof | |
CN117100646A (en) | Composition containing pollen pini extract and application thereof | |
TW202029977A (en) | Use of physalis angulata linn. fruits extract for enhancing the gene expression level of tgm, and/or krt | |
TW202010507A (en) | Use of extract of rhinacanthus communis callus tissue for inducing expression of collagen type i gene, eln gene, has3 gene, xrcc1 gene, msh gene, sod1 gene, gpx1 gene, cat gene, tgm gene and aqp gene, promoting collagen production, and anti-oxidation, method for inducing and proliferating rhinacanthus communis callus tissue, and medium for culturing rhinacanthus communis callus tissue | |
CN115701348A (en) | Bai Lusun enzyme and application thereof in improving skin condition, physiological metabolism and kidney function | |
TW202017580A (en) | Use of anethum graveolens seed extracts for decreasing brain nerve cell damage and slowing down neuronal apoptosis |